- News & Views
- Published:
MULTIPLE SCLEROSIS
Mounting evidence for a multiple sclerosis prodrome
Nature Reviews Neurologyvolume 15, pages689–690 (2019)Cite this article
1043Accesses
6Citations
12Altmetric
A new study provides direct biological evidence for a prodromal phase of multiple sclerosis (MS), with implications for studying disease aetiology and underscoring the limitations of therapies that solely target inflammation. The findings also suggest an opportunity to apply secondary prevention strategies at the very earliest stages of the disease.
This is a preview of subscription content,access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
9,800 Yen / 30 days
cancel any time
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout
References
Bjornevik, K. et al. Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis.JAMA Neurol.https://doi.org/10.1001/jamaneurol.2019.3238 (2019).
Mankia, K. & Emery, P. Review: Preclinical rheumatoid arthritis: progress toward prevention.Arthritis Rheumatol.68, 779–788 (2016).
Berg, D. et al. MDS research criteria for prodromal Parkinson’s disease.Mov. Disord.30, 1600–1611 (2015).
Okuda, D. T. et al. Radiologically isolated syndrome: 5-year risk for an initial clinical event.PLoS ONE9, e90509 (2014).
Wijnands, J. M. A. et al. Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study.Lancet Neurol.16, 445–451 (2017).
Wijnands, J. M. et al. Five years before multiple sclerosis onset: phenotyping the prodrome.Mult. Scler.25, 1092–1101 (2019).
Disanto, G. et al. Prodromal symptoms of multiple sclerosis in primary care.Ann. Neurol.83, 1162–1173 (2018).
Wiberg, M. et al. Earnings among people with multiple sclerosis compared to references, in total and by educational level and type of occupation: a population-based cohort study at different points in time.BMJ Open9, e024836 (2019).
Cortese, M. et al. Pre-clinical disease activity in multiple sclerosis: a prospective study on cognitive performance prior to first symptom.Ann. Neurol.80, 616–624 (2016).
US National Library of Medicine.Clinicaltrials.govhttps://clinicaltrials.gov/ct2/show/NCT02603146 (2019).
Acknowledgements
This article was supported (in part) by a Manitoba Research Chair from Research Manitoba, and the Waugh Family Chair in Multiple Sclerosis.
Author information
Authors and Affiliations
Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
Ruth Ann Marrie
- Ruth Ann Marrie
Search author on:PubMed Google Scholar
Corresponding author
Correspondence toRuth Ann Marrie.
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Marrie, R.A. Mounting evidence for a multiple sclerosis prodrome.Nat Rev Neurol15, 689–690 (2019). https://doi.org/10.1038/s41582-019-0283-0
Published:
Version of record:
Issue date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
The multiple sclerosis prodrome
- Naila Makhani
- Helen Tremlett
Nature Reviews Neurology (2021)
